Brief: Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
08/01/2026 14:47
Jan 8 (Reuters) - ZYUS Life Sciences Corp ZYUS.V: ZYUS LIFE SCIENCES REPORTS PRELIMINARY RESULTS FROM ONGOING PHASE 2A UTOPIA-1 TRIAL EVALUATING NOVEL NON-OPIOID PAIN DRUG ZYUS LIFE SCIENCES CORP - EARLY DATA FROM PHASE 2A UTOPIA-1 TRIAL SUGGESTS IMPROVEMENT IN PAIN EFFICACY ZYUS LIFE SCIENCES CORP - TRICHOMYLIN® SOFTGEL CAPSULES WELL TOLERATED, MILD REACTIONS Source text: ID:nPn4j1TrGa Further company coverage: ZYUS.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zyus Life Sciences
See all newsBrief: Zyus Life Sciences Announces Strategic Realignment To Prioritize Drug Development
Brief: Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
Brief: ZYUS Life Sciences Provides Update On Clinical Trial Progress And Unit Private Placement
Brief: Zyus Closes First Tranche Of Unit Offering, Issues Warrants Under Loan Agreements And Note Amendment
Brief: Zyus Life Sciences Corporation Announces Closing Of Additional Secured Loan